Skip to main content
. 2022 Apr 24;27(7):e589–e596. doi: 10.1093/oncolo/oyac067

Figure 1.

Figure 1.

Forest plot of PFS among ASCT-ineligible patients with high-risk NDMM from MAIA and ALCYONE, separately and pooled.

Abbreviations: ASCT, autologous stem cell transplant; CI, confidence interval; HR, hazard ratio; NDMM, newly diagnosed multiple myeloma; PFS, progression-free survival.

aFor the pooled analysis, a multivariate stratified Cox regression analysis was used to calculate adjusted HR, with the study identifier as the stratification factor. HR was adjusted for cytogenetic abnormalities [ie, del(17p), t(4, 14), 4(14, 16)], baseline Eastern Cooperative Oncology Group performance status, International Staging System stage, type of multiple myeloma (ie, IgG vs. non-IgG), and renal impairment (defined as creatinine clearance <60 mL/minute).